Abstract
Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have